Boryung launches new ulcer drug

Published: 2009-07-02 06:56:00
Updated: 2009-07-02 06:56:00
Boryung Pharm said it has recently released Stogar (lafutidine), a newly developed histamine H(2)-receptor antagonist.

Stogar is indicated for treatment of Helicobacter pylori and inhibits daytime (i.e., postprandial) as well as nighttime gastric acid secretion in clinical studies.

Boryung ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.